Invokana, a drug released in 2013 for the treatment of Type 2 Diabetes, has drawn a lot of attention in the last year. Invokana, along with several other SGLT2 inhibitors, has now been linked to severe side effects such as: kidney failure, ketoacidosis, heart attack, and more.
Injury Lawsuits Already Being Pursued
Many lawsuits filed have claimed that the manufacturers, Janssen Pharmaceuticals, and the parent company, Johnson & Johnson, knew about the increase in extreme side effects of the drug they were marketing and chose not to warn the public or provide proper information to the medical community.
One such lawsuit was filed by a woman from Louisville, Kentucky. The woman alleged that her prescriptions for the drugs Invokana and Farxiga caused Ketoacidosis. Ketoacidosis is a serious condition that can lead to a diabetic coma, or even death. Invokana was the first gliflozin to be approved in the U.S. According to court documents, soon after the drug was released the FDA began to receive “a significant number of reports” of diabetic ketoacidosis. A later analysis of the events showed that those taking any one of the SGLT2 inhibiting drugs are several times more likely to report ketoacidosis and kidney failure than those taking alternative diabetes drugs.
Another lawsuit was filed in the Southern District of Illinois. The plaintiff suffered severe kidney damage after using Invokana. The Illinois man is now pursuing over $75,000 in compensatory and punitive damages. Invokana inhibits the reabsorption of glucose into the kidneys. However, it also increases the amount of creatine passing through the kidneys.
How Does Invokana Cause Injuries?
When those taking Ivokana begin to have exceedingly high levels of creatine, the kidneys will begin to returning the substance to the bloodstream instead of releasing it in the urine. This can lead to impaired kidney function and failure. According to the Legal Examiner, the FDA has had at least 19 cases of life-threatening blood and/or kidney infections associated with Invokana.
The New York Times brought attention to the clinical reports on Invokana that showed observations that the drug increases the heart rate, and may cause other heart issues as well. Clinical trials have also revealed that 13 patients had major cardiac events, including stroke and heart attack, within the first 30 days of treatment. Diabetics are already at risk for heart disease and any cardiac event can be more dangerous for a diabetic.
The FDA mandated that Janssen Pharmaceuticals include additional safety warnings and conduct additional studies of the severe side effects of the drug. If you are a loved one has experienced diabetic ketoacidosis, kidney failure, a heart attack, or other serious injuries as a direct result of the Invokana drug, you may be entitled to financial compensation.
The attorneys at Davis Law Group have been representing injury victims across the country for more than 20 years. If you or a loved one has suffered after taking Invokana, it may be in your best interests to consult with a personal injury attorney. Our case investigation team is available 24 hours a day to discuss the merits of your claim and help you better understand your legal options. Contact us today at (206) 727-4000 or by using the contact form on this page to have your case reviewed free of charge.